GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 17 filers reported holding GAIN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91,594 | -29.6% | 27,925 | -3.8% | 0.00% | – |
| Q2 2023 | $130,027 | +8.9% | 29,024 | +17.1% | 0.00% | – |
| Q1 2023 | $119,430 | +52.7% | 24,778 | -0.8% | 0.00% | – |
| Q4 2022 | $78,188 | +4.3% | 24,980 | +9.1% | 0.00% | – |
| Q3 2022 | $75,000 | -11.8% | 22,901 | -2.7% | 0.00% | – |
| Q2 2022 | $85,000 | +97.7% | 23,541 | +121.3% | 0.00% | – |
| Q1 2022 | $43,000 | -28.3% | 10,637 | -4.7% | 0.00% | – |
| Q4 2021 | $60,000 | -29.4% | 11,159 | -2.8% | 0.00% | – |
| Q3 2021 | $85,000 | -26.7% | 11,476 | -1.6% | 0.00% | – |
| Q2 2021 | $116,000 | – | 11,659 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 90,000 | $295,200 | 0.31% |
| Greenlight Capital | 588,410 | $1,929,985 | 0.11% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $190,568 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 46,100 | $148,903 | 0.00% |
| Householder Group Estate & Retirement Specialist, LLC | 2,500 | $8,200 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HM PAYSON & CO | 1,000 | $3,280 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,937 | $6,257 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 151,476 | $489,355 | 0.00% |
| MORGAN STANLEY | 1,300 | $4,264 | 0.00% |